- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02392715
Inspiratory Muscle Training Combined With General Exercise Training in COPD (IMTGET)
Inspiratory Muscle Training Combined With General Exercise Training, Compared to General Exercise Training Alone in Patients With COPD: Randomized Controlled Trial
Study Overview
Status
Conditions
Detailed Description
Prospective, parallel-group, randomized controlled trial
80 COPD patients will be randomized into two groups. One group will receive general exercise training combined with inspiratory muscle training, 3 times a week, for a total of 36 sessions. The other group will receive general exercise training combined with shame inspiratory muscle training, 3 times a week, for a total of 36 sessions.
We will assess the difference of improvement in exercise capacity between the 2 groups with the 6 minute walking test. We will also assess the difference of improvement in quality of life with St-George's respiratory questionnaire. Finally the difference of improvement in maximal inspiratory pressure will be determined.
Patients and investigators assessing the outcomes will be blinded to group allocation.
Written informed consent will be obtained from each subject. The data will be treated anonymously.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- COPD demonstrated by spirometry using Gold Criteria
- Patient referred by a pneumologist to the ambulatory pulmonary rehabilitation program at the Riviera-Chablais Hospital, Monthey
- Patient with maximal inspiratory pressure < 60 cmH20
- Patient older than 40 years
Exclusion Criteria:
- Orthopaedic or neurological troubles that could slant the 6 minute walking test
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Intervention cohort
36 sessions of 60 - 75 minutes with a frequency of 3x/week 30' endurance training, 15' strength training, 15' inspiratory muscle training with Threshold by Respironics Inspiratory muscle training intensity: 15% of maximal inspiratory pressure (PiMax) during the first week. Then increment of 5% each session until 60% of PiMax after the first month. The PiMax will be reassessed after 12 and 24 sessions in order to readjust the 60% of PiMax. |
Inspiratory muscle training 15 minutes, 3x/weeks, 36 sessions Intensity: 15% of PiMax during the first week. Then increment of 5% each session until 60% of PiMax after the first month. The PiMax will be reassessed after 12 and 24 sessions in order to readjust the 60% of PiMax. |
|
Sham Comparator: Control cohort
36 sessions of 60 - 75 minutes with a frequency of 3x/week 30' endurance training, 15' strength training, 15' sham inspiratory muscle training with Threshold by Respironics Sham inspiratory muscle training intensity : 5 centimeters of water (cmH20) |
with Threshold by respironics 15 minutes, 3x/weeks, 36 sessions Intensity: 5 centimeters of water (cmH20) |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Exercise capacity (six minute walking test)
Time Frame: 12 weeks
|
exercise capacity will be assessed by a six minute walking test
|
12 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Quality of Life (St-George's Respiratory questionnaire)
Time Frame: 12 weeks
|
Quality of Life will be assessed by St-George's Respiratory questionnaire
|
12 weeks
|
|
Maximal inspiratory pressure (MicroRPM by MicroMedical)
Time Frame: 12 weeks
|
Inspiratory maximal pressure will be assessed by the MicroRPM by MicroMedical
|
12 weeks
|
Collaborators and Investigators
Investigators
- Principal Investigator: Stéphanie Vaudan, BSc, stephanie.vaudan@hopitalrivierachablais.ch
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 003/15
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Obstructive Pulmonary Disease
-
Spire, Inc.ResMedCompletedSevere Chronic Obstructive Pulmonary Disease | Moderate Chronic Obstructive Pulmonary DiseaseUnited States
-
University of LeicesterUniversity Hospitals, Leicester; University of StrathclydeRecruitingChronic Obstructive Pulmonary Disease (COPD) | Chronic Obstructive Lung Disease | Chronic Obstructive Airway DiseaseUnited Kingdom
-
National Taipei University of Nursing and Health...TerminatedChronic Pulmonary Disease | Chronic Obstructive Pulmonary Disease Exacerbation | Chronic Obstructive Pulmonary Disease With ExacerbationTaiwan
-
Karaganda Medical UniversityCompletedChronic Obstructive Pulmonary Disease | Chronic Obstructive Pulmonary Disease Moderate | Chronic Obstructive Pulmonary Disease SevereKazakhstan
-
Randall DebattistaUniversity of Malta, Faculty of Health SciencesNot yet recruitingChronic Obstructive Pulmonary Disease Moderate | Acute Exacerbation of COPD | Chronic Obstructive Pulmonary Disease Severe
-
Cukurova UniversityCompletedAnesthesia | Chronic Obstructive Pulmonary Disease Moderate | Lungcancer | Chronic Obstructive Pulmonary Disease Severe | Chronic Obstructive Pulmonary Disease MildTurkey
-
Taipei Medical UniversityUnknownChronic Obstructive Pulmonary Disease Severe | Chronic Obstructive Pulmonary Disease End StageTaiwan
-
Hopital FochAir Liquide SARecruitingChronic Obstructive Pulmonary Disease SevereFrance
-
Fundación para la Investigación del Hospital Clínico...Not yet recruitingCOPD, Chronic Obstructive Pulmonary DiseaseSpain
-
Canandaigua VA Medical CenterRecruitingChronic Obstructive Pulmonary Disease ModerateUnited States
Clinical Trials on Inspiratory muscle training with Threshold by respironics
-
Universitas PadjadjaranDr. Hasan Sadikin General Hospital, Bandung, IndonesiaNot yet recruitingChronic Obstructive Pulmonary Disease (COPD) | Diaphragm Dysfunction
-
The University of QueenslandUnknownRenal Failure | Chronic Renal InsufficiencyAustralia
-
University of ValenciaCompletedSarcopenia | Syndrome; InstitutionalizationSpain
-
Guangzhou Institute of Respiratory DiseaseCompletedChronic Obstructive Pulmonary Disease
-
Cliniques universitaires Saint-Luc- Université...Unknown
-
Cliniques universitaires Saint-Luc- Université...Completed
-
Clínica BasileaNot yet recruitingPhysical Therapy Modalities, Respiratory Muscles, Maximal Respiratory Pressures, Breathing Exercise
-
Singapore General HospitalUnknownPerioperative/Postoperative Complications | Complication, PostoperativeSingapore
-
Cairo UniversityRecruitingGuillain-Barre SyndromeEgypt
-
University of ValenciaCompletedMuscle Weakness | Cardiovascular Morbidity | Respiratory Morbidity | Syndrome; InstitutionalizationSpain